MTM Patient-Centered Care & Communication 4 — Questions and Answers
Question 1: During an MTM encounter, a patient becomes emotional while discussing difficulty affording insulin. Which pharmacist response demonstrates the HIGHEST level of empathy?
- 'I understand. Let me look up some discount programs for you.'
- 'Many patients face this problem; you are not alone.'
- 'It sounds like managing the cost of insulin is really weighing on you. Can you tell me more about what you're dealing with?' (Correct answer)
- 'Your doctor should be prescribing a less expensive option.'
Correct answer: 'It sounds like managing the cost of insulin is really weighing on you. Can you tell me more about what you're dealing with?'
Reflecting the emotional content and inviting elaboration demonstrates the deepest empathy and validates the patient's experience.
Question 2: Which of the following BEST describes 'shared decision-making' in an MTM context?
- The pharmacist decides the best medication regimen and informs the patient
- The prescriber and pharmacist jointly select medications without patient input
- The patient and clinician collaborate, combining clinical evidence with patient preferences to reach a treatment decision (Correct answer)
- The patient independently selects their medications based on online research
Correct answer: The patient and clinician collaborate, combining clinical evidence with patient preferences to reach a treatment decision
Shared decision-making is a collaborative process where both clinical evidence and patient preferences are integrated into treatment choices.
Question 3: A pharmacist identifies a patient who is a 'low health activator' on the Patient Activation Measure (PAM). Which approach is MOST appropriate?
- Focus on complex self-management skills and lifestyle changes
- Set small, confidence-building goals and provide strong support (Correct answer)
- Refer the patient to their physician for all management decisions
- Provide comprehensive written materials and schedule a 6-month follow-up
Correct answer: Set small, confidence-building goals and provide strong support
Low-activation patients need confidence-building through small achievable wins and strong pharmacist support before tackling complex changes.
Question 4: A patient with type 2 diabetes states they follow a traditional diet high in rice and beans. How should the pharmacist address dietary counseling?
- Advise the patient to eliminate rice and beans entirely to control blood sugar
- Acknowledge the cultural significance of the diet and explore portion modification strategies together (Correct answer)
- Refer the patient to a dietitian without discussing diet further
- Document non-compliance with dietary guidelines in the chart
Correct answer: Acknowledge the cultural significance of the diet and explore portion modification strategies together
Culturally sensitive counseling acknowledges the patient's food traditions and explores realistic modifications rather than demanding elimination.
Question 5: The 'Ask Me 3' program encourages patients to ask their healthcare providers three key questions. Which question is INCLUDED in Ask Me 3?
- 'What is the generic name of my medication?'
- 'What is my main problem?' (Correct answer)
- 'How many refills am I allowed?'
- 'Which insurance plan covers this medication?'
Correct answer: 'What is my main problem?'
Ask Me 3 prompts patients to ask: What is my main problem? What do I need to do? Why is it important for me to do this?
Question 6: When a patient expresses resistance to starting a new medication, which motivational interviewing strategy involves highlighting the gap between the patient's current behavior and their stated health goals?
- Rolling with resistance
- Developing discrepancy (Correct answer)
- Expressing empathy
- Supporting self-efficacy
Correct answer: Developing discrepancy
Developing discrepancy highlights the conflict between a patient's current behavior and their own goals to create internal motivation for change.
Question 7: Which of the following is the MOST appropriate follow-up interval for a high-risk patient newly initiated on anticoagulation therapy after an MTM comprehensive medication review?
- 12 months
- 6 months
- 3 months
- 2 to 4 weeks (Correct answer)
Correct answer: 2 to 4 weeks
High-risk patients on anticoagulation require close follow-up within 2 to 4 weeks to assess safety, adherence, and INR stability.
MTM Patient-Centered Care & Communication 4
During an MTM encounter, a patient becomes emotional while discussing difficulty affording insulin.
Which pharmacist response demonstrates the HIGHEST level of empathy?